PEC0747 Walk the talk: Engaging community in the HIV research agendaE-posterC52
PED1016 Walking a fine line: Understanding the overlap of sex work and young women in South AfricaE-posterD34
PEF1840 War on drugs: Opportunities in accessing to harm reduction services for people who use drugs in Mombasa CountyE-posterF40
PED1176 We are all women: Barriers and facilitators to inclusion of transgender women in HIV treatment and support services designed for cisgender womenE-posterD46
PEB0233 Weight change among treatment naive women initiating dolutegravir in the ARIA studyE-posterB30
PEB0199 Weight change before and after switching therapy to tenofovir alafenamide (TAF) in virologically suppressed (VS) personsE-posterB22
OAB0605 Weight changes after switching to doravirine/lamivudine/TDF in the DRIVE-SHIFT trialOral abstract session with live Q&AB22
OAB0602 Weight gain and hyperglycemia during the dolutegravir transition in AfricaOral abstract session with live Q&AB21
PEB0197 Weight gain associated with antiretroviral therapy in HIV-infected individuals is affected by multiple factorsE-posterB22
OAB0604 Weight gain before and after switch from TDF to TAFOral abstract session with live Q&AB22
seek-warrow-warrow-eseek-e2241 - 2250 of 2297 items